The Impact of AI on Drug Development and Healthcare
VeriSIM Life, an AI-driven technology company, has developed "digital twins" of human and animal biology to test the impact of pharmaceuticals before clinical trials. The technology replaces animal testing, reducing costs and time, and ultimately reducing risk for drug developers. The platform can test millions of hypotheses, generating new compounds quickly. The technology is also used to develop drugs for smaller populations of patients that pharmaceutical companies might not have been able to financially justify with traditional R&D costs. VeriSIM's mission to reduce animal testing has been applauded by the FDA.